UNBELIEVABLE: Moderna | History Defined

Why Citi Is Sounding the Alarm on Moderna Stock

The cancer pipeline gave Moderna's shares a rocket boost. Citi, however, just checked the stock’s price tag and wasn’t exactly impressed.

Barchart · Oct 1

This Analyst Just Downgraded Moderna Stock. Here's Why.

Citi analyst says Moderna stock could crash as much as 60% from here. Here’s why he issued a bearish note on MRNA shares today.

Barchart · Sep 30

Unusual Options Activity in Microsoft Stock Is Already Paying Off (and 3 Other Stocks to Watch)

Microsoft's 14,875-contract bull call spread ($525/$600, Oct. 30) gained 3% in one day. For non-tech alternatives, Robinhood's $123/$128 call spread, Moderna's $195/$205 combo (already profitable), and ExxonMobil's $167.50/$172.50 spread offer varying risk/reward, though XOM's breakeven exceeds its analyst target price.

Barchart · Sep 25

The FDA just approved this year’s Covid vaccines - here’s what you need to know about the shots

The vaccines are expected to roll out at hospitals and pharmacies in just days

The Independent UK · Aug 28

Updated COVID Shots Matched to the XFG Variant Reach Pharmacies While Federal Eligibility Guidance Remains Unsettled

FDA approved updated 2026-2027 COVID vaccines targeting XFG. Here is who qualifies, what insurance covers, and what guidance is still missing.

Medical Daily · Aug 28

Dolly Parton once gave $1 million to help develop the Moderna COVID vaccine at Vanderbilt: ‘I’m kind of addicted to the feeling of giving’

Dolly Parton had a $450 million fortune at her passing, but spent much of her life giving it away—including $1 million toward COVID-19 vaccine research.

Fortune · Aug 26

Wolfe Research Just Upgraded Moderna Stock. Here's Why.

Moderna stock rallies as Wolfe Research upgrades it to "Peer Perform." But is there any further upside left in MRNA shares? Let’s find out!

Barchart · Aug 25

US stocks today: US stocks close higher on tech rebound as Nvidia earnings gain focus

US stocks closed higher as technology and semiconductor shares recovered ahead of Nvidia's earnings. Lower oil prices and Treasury yields offered relief, while investors assessed AI spending and stretched valuations. Weak consumer confidence added to economic concerns, with upcoming PCE inflation data and Fed commentary keeping rate expectations in focus.

The Economic Times · Aug 25

Moderna Added 45 Billion Dollars in a Day on a Melanoma Vaccine Result with No Effect Size Disclosed

Moderna and Merck's melanoma vaccine met its Phase 3 goals, but no effect size was released, and some analysts called the market reaction excessive.

Medical Daily · Aug 25

BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing

BioNTech shares moved higher as the broader biotech sector reached a post-pandemic peak, lifted by positive late-stage cancer vaccine data from peers rather than new clinical results of its own.

Barchart · Aug 24